TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration	Neovascular Age-related Macular Degeneration	Active, not recruiting	Phase 3	2025-01-07		NCT05461339

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioDlink Biopharm Co., Ltd.	1
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.	7

56 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Eye Hospital of Nanchang University	Nanchang	China	1
Affiliated Hospital of Zunyi Medical University	Zunyi	China	17
Aier Eye Hospital(Changsha)	Changsha	China	1
Beijing Aier Intech Eye Hospital	Beijing	China	2
Beijing Hospital	Beijing	China	33
Beijing Tongren Hospital, Cmu	Beijing	China	1
Cangzhou Central Hospital	Cangzhou	China	2
Central theater General Hospital	Wuhan	China	1
Changzhi People'S Hospital	Changzhi	China	9
Chengdu Aier Eye Hospital	Chengdu	China	1
Dalian No.3 People'S Hospital	Dalian	China	1
Eye Hospital, WMU	Wenzhou	China	2
Guangzhou First People's Hospital	Guangzhou	China	15
Hebei Eye Hospital	Xingtai	China	2
Henan Eye Hospital& Henan Eye Institute	Zhengzhou	China	1
Hunan Provincial People's Hospital	Changsha	China	12
Ineye Hospital of Chengdu University of TCM	Chengdu	China	1
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong	Shantou	China	1
Kaifeng Central Hopital	Kaifeng	China	1
Peking Union Medical College Hospital	Beijing	China	62
Peking University People's Hospital	Beijing	China	146
Peking University Third Hospital	Beijing	China	123
Renmin Hospital of Wuhan University	Wuhan	China	42
Shanghai Eye Disease Prevention and Treatment Center	Shanghai	China	1
Shanghai General Hospital	Shanghai	China	59

Clinical trials